Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

TPST Relative to the S&P 500

TPST Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Tempest Therapeutics Inc. (NASD:TPST) seasonal charts above shows that a Buy Date of August 13 and a Sell Date of November 5 has resulted in a geometric average return of 3.43% above the benchmark rate of the S&P 500 Total Return Index over the past 13 years. This seasonal timeframe has shown positive results compared to the benchmark in 6 of those periods. This is a poor rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 13 years by an average of 103.43% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. Tempest Therapeutics was founded in 2011 and is headquartered in Brisbane, CA.

To download TPST seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: TPST